OTC Pediatrics - US - November 2010
US $4,395.00 (Excl.Tax)Excl. Tax Buy Now
With the exception of a sales boost in 2009 motivated by the H1N1 flu pandemic, the children’s over-the-counter (OTC) remedy market has suffered over the last three years from negative publicity resulting from a steady stream of events, including multiple recalls, a plant closing, and an ongoing inquiry into the safety and efficacy of cough and cold products for children. These events appear to have reinforced parents’ instinctive caution concerning the medicines they give their children. Putting the category back on a growth track will require concerted efforts from both manufacturers and retailers to rebuild parents’ trust.
This report offers in-depth analysis of the OTC pediatric remedies market, including:
This report will give you a complete 360-degree view of your market. Not only is it rooted in robust proprietary and high-quality third-party data, but our industry experts put that data into context and you’ll quickly understand:
What They Want. Why They Want It.
Who’s Winning. How To Stay Ahead.
Size, Segments, Shares And Forecasts: How It All Adds Up.
New Ideas. New Products. New Potential.
Where The White Space Is. How To Make It Yours.
What’s Shaping Demand – Today And Tomorrow.